Abivax SA (2X1) Financial Statements
Abivax SA Financial Overview
Abivax SA's market cap is currently $6.92B. The company's EPS TTM is $-4.71; its P/E ratio is -16.78; Abivax SA is estimated to report earnings on December 14, 2026, and the estimated EPS forecast is $-0.81. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Mar 24 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 10.79M | $ 4.62M | $ 4.58M | $ 37.00K |
| Gross Profit | $ -1.07M | $ 10.79M | $ 4.49M | $ 4.51M | $ -119.00K |
| Operating Income | $ -250.63M | $ -185.43M | $ -127.38M | $ -64.84M | $ -52.19M |
| EBITDA | $ -249.55M | $ -167.68M | $ -133.21M | $ -53.31M | $ -42.20M |
| Net Income | $ -336.10M | $ -176.24M | $ -147.74M | $ -60.74M | $ -42.45M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 530.38M | $ 144.22M | $ 260.99M | $ 26.95M | $ 60.70M |
| Total Assets | $ 584.34M | $ 205.23M | $ 327.06M | $ 73.35M | $ 110.36M |
| Total Debt | $ 32.09M | $ 97.36M | $ 55.46M | $ 39.16M | $ 53.45M |
| Net Debt | $ -484.59M | $ -46.86M | $ -196.48M | $ 19.78M | $ -7.25M |
| Total Liabilities | $ 129.14M | $ 164.64M | $ 131.05M | $ 71.47M | $ 81.59M |
| Stockholders' Equity | $ 455.20M | $ 40.58M | $ 196.01M | $ 7.19M | $ 25.93M |
| Cash Flow | |||||
| Free Cash Flow | $ -162.23M | $ -154.72M | $ -97.39M | $ -69.55M | $ -47.30M |
| Operating Cash Flow | $ -162.09M | $ -154.07M | $ -97.13M | $ -65.58M | $ -45.66M |
| Investing Cash Flow | $ -13.72M | $ 15.76M | $ -8.10M | $ -3.73M | $ -1.46M |
| Financing Cash Flow | $ 553.80M | $ 28.21M | $ 335.29M | $ 32.21M | $ 82.68M |
Currency in EUR